Under construction – not a live service
Sign in
Taking people in NetherlandsNo phase

Observational Registry Following Heart Conditions Through Routine Cardiac Testing

Collects routine heart test results from people with heart failure, arrhythmias, or coronary artery disease.

Plain-language title generated from the registry record
Registry title: The Multicenter Cardiology Monitoring Platform Registry

Key facts

Where
Maastricht, NetherlandsSee the site

Where in Netherlands

  • Maastricht UMCMaastricht, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Maastricht University Medical Center
Trial code
NCT04976348
Record updated
19 October 2026
Original description
The multicenter Cardiology Monitoring Platform registry (mCMP-registry) is a prospective observational registry including multi-omics (diagnostic) measurements performed as part of routine clinical care, bio-banking (optional), and yearly questionnaires (optional).Read full original descriptionShow less

The Multicenter Cardiology Monitoring Platform Registry (mCMP-registry)

The multicenter Cardiology Monitoring Platform registry (mCMP-registry) is a prospective observational registry including multi-omics (diagnostic) measurements performed as part of routine clinical care, bio-banking (optional), and yearly questionnaires (optional).

It's objective is to optimize (early) diagnosis and risk-stratification of (early) cardiovascular diseases, specifically cardiomyopathy phenotypes, arrhythmias, and coronary artery disease, and to create a better understanding of underlying pathophysiological processes.

Inclusion: Referred to the cardiology or genetic department for heart failure like symptoms (as stated in the ESC 2016 Guidelines(3)) or for cardiac/cardiogenetic screening; Age ≥16 years.

Exclusion: Unwillingness to participate or unable to give written informed consent (e.g. due to language barriers or severe intellectual disability).

ClinicalTrials.gov NCT04976348